Predictive Value of the Neutrophil to Lymphocyte Ratio (NLR) to Predict the Development of Preeclampsia and Pregnancy Induced Hypertension at 1st Trimester
Introduction:Hypertensive disorder in pregnancy affects 4 to 6 percent of all pregnancies and carries risks for the both baby and the mother. Only a few groups of women who are at high-risk pregnancies are received prophylaxis Aspirin, more than 15 percent of women develop pre-eclampsia with a single minor risk factor. Methods:This descriptive cross-sectional study was conducted to compare the 1st trimester NLR value of normotensive, pregnancy induced hypertensive and pre-eclamptic pregnant women. The study was conducted with a sample of 416, antenatal patients who were admitted to ward 25, at Colombo North Teaching Hospital Ragama. Data was collected as separated three groups. NLR value was calculated separately and ANOVA test was used to analyze the 3 categorical data. Post HOC test was done to assess the multiple comparison. Results:The prevalence rates of pregnancy induced hypertension and pre-eclampsia among the pregnant women were 8.6% and 5.7%. The mean NLR values of normotensive group was 2.708, pregnancy induced hypertensive group was 2.650 and pre eclamptic group was 3.789. There was a significant difference in NLR value between pre eclamptic group and other two groups with P value of <0.001 (Corresponding 95% upper bound for the CI: −0.7132). There was no significant difference of the NLR vales of normotensive and pregnancy induced hypertensive groups (P value of 0.894). Conclusion:The 1st trimester NLR value of pre eclamptic patients significantly increased compared to normotensive women.
References
[1]
NICE (2010) Guideline Hypertension in Pregnancy Diagnosis and Management, 35109334009285.
[2]
Stewart, F.M., Freeman, D.J., Ramsay, J.E., Greer, I.A., Caslake, M. and Ferrell, W.R. (2007) Longitudinal Assessment of Maternal Endothelial Function and Markers of Inflammation and Placental Function throughout Pregnancy in Lean and Obese Mothers. The Journal of Clinical Endocrinology and Metabolism, 92, 969-975. https://doi.org/10.1210/jc.2006-2083
[3]
Barker, D.J.P., Bull, A.R. and Osmond, C. (1990) Fetal and Placental Size and Risk of Hypertension in Adult Life. BMJ, 301, 259-261. https://doi.org/10.1136/bmj.301.6746.259
[4]
Benyo, D.F., Smarason, A., Redman, C.W., et al. (2001) Expression of Inflammatory Cytokines in Placentas from Women with Preeclampsia. The Journal of Clinical Endocrinology and Metabolism, 86, 2505-2512. https://doi.org/10.1210/jc.86.6.2505
[5]
Canzoneri, B.J., Lewis, D.F., Groome, L., et al. (2009) Increased Neutrophil Numbers Account for Leukocytosis in Women with Preeclampsia. American Journal of Perinatology, 26, 729-732. https://doi.org/10.1055/s-0029-1223285
[6]
Roberts, J.M., Taylor, R.N., Musci, T.J., et al. (1989) Pre-Eclampsia: An Endothelial Cell Disorder. American Journal of Obstetrics and Gynecology, 161, 1200-1204. https://doi.org/10.1016/0002-9378(89)90665-0
[7]
Myers, J.E., Kenny, L.C., Mccowan, L.M.E., et al. (2011) Angiogenic Factors Combined with Clinical Risk Factors to Predict Preterm Pre-Eclamspia in Nulliparous Women: A Predictive Test Accuracy Study. BJOG, 120, 1215-1223. https://doi.org/10.1111/1471-0528.12195
[8]
Aygün, F. and Efe, D. (2015) Association of Neutrophil/Lymphocyte Ratio with Obstructive Coronary Artery Disease and Coronary Artery Calcium Score Detected by Multislice Computed Tomography in Type 2 Diabetes Mellitus Patients. Patient Prefer Adherence, 9, 1023-1031. https://doi.org/10.2147/PPA.S85577
[9]
Yilmaz, H., Celik, H.T., Namuslu, M., et al. (2014) Benefits of the Neutrophil-to-Lymphocyte Ratio for the Prediction of Gestational Diabetes Mellitus in Pregnant Women. Experimental and Clinical Endocrinology & Diabetes, 122, 39-43. https://doi.org/10.1055/s-0033-1361087
[10]
Kurtoglu, E., Kokcu, A., Celik, H., Tosun, M. and Malatyalioglu, E. (2014) May Ratio of Neutrophil to Lymphocyte Be Useful in Predicting the Risk of Developing Preeclampsia? A Pilot Study. The Journal of Maternal-Fetal & Neonatal Medicine, 28, 97-99. https://doi.org/10.3109/14767058.2014.905910
[11]
Lwanga, S.K. and Lemeshow, S. (1991) Sample Size Determination in Health Studies. A Practical Manual. World Health Organization.